HPTLC Method for estimation of Gallic acid and Rutin in Haritaki -An Ayurvedic Formulation

Similar documents
Development And Validation Of HPTLC Method For Simultaneous Estimation Of Rutin And Quercetin In Hydroalcoholic Extract Of Triphala Churna

JPSBR: Volume 4, Issue 6: 2014 ( ) ISSN NO

Development and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast

Development And Validation Of UV Spectrophotometric Method For Simultaneous Estimation Of Rutin And Gallic Acid In Hydroalcoholic Extract Of

Development and Validation of Improved RP-HPLC method for Identification and Estimation of Ellagic and Gallic acid in Triphala churna

Vol-3, Issue-4, Suppl-1, Nov 2012 ISSN: Ghodasara et al PHARMA SCIENCE MONITOR

Available online at Universal Research Publications. All rights reserved. Original Article

Development and Validation of HPTLC Method for Estimation of Tramadol HCl in Bulk and in Capsule Dosage Form

Available Online through Research Article

Department of Pharmaceutical Analysis, KMCH College of Pharmacy, Coimbatore-35, India

Validation of HPTLC Method for Quantification of Embelin from Embelia ribes Burm. F.

Development and Validation of HPTLC Method for Quantification of Silodosin in Bulk and Pharmaceutical Dosage Form


Abs. tract. author: *Corresponding. Kumar Puspendra. Panchsakar Churna. HPTLC. efficient validated for tested in the. Group. India. and 50.

ESTIMATION OF GALLIC ACID IN TERMINELLIA CHEBULA LINN. FRUIT BY VALIDATED HPTLC METHOD

DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR ESTIMATION OF ALOGLIPTIN BENZOATE IN BULK DRUGS AND TABLET DOSAGE FORMS

Vol-3, Issue-4, Suppl-1, Nov 2012 ISSN: Shingala et al PHARMA SCIENCE MONITOR

Simultaneous Estimation and Validation of Tramadol and Paracetamol by HPTLC in Pure and Pharmaceutical Dosage Form

Comparative HPTLC Analysis of Leaves of Allium cepa L., Ficus carica L. and Ziziphus mauritiana L. with Standard Quercetin

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

A HPTLC method for chemotaxonomic evaluation of some Curcuma Species and their commercial samples

HPTLC Determination of Atomoxetine Hydrochloride from its Bulk Drug and Pharmaceutical Preparations

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES

J Pharm Sci Bioscientific Res (4): ISSN NO

Scholars Research Library

Stability indicating thin-layer chromatographic determination of eslicarbazepine acetate as bulk drug: Application to forced degradation study

THIN LAYER CHROMATOGRAPHY

Validated UV Spectrophotometric Method Development And Stability Studies Of Acamprosate Calcium In Bulk And Tablet Dosage Form

Simultaneous Estimation of Salbutamol Sulphate and guaiphenesin in their Combined Liquid Dosage Form by HPTLC Method

Validated Spectrophotometric Method for Simultaneous Estimation of Atorvastatin and Nicotinic acid in Combined Pharmaceutical dosage form

International Journal of Pharma and Bio Sciences

STABILITY INDICATING ASSAY. differentiate an intact drug from its potential decomposition products 425.


DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPTLC METHOD FOR ESTIMATION OF GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Scholars Research Library

Amudha S et al., Asian Journal of Pharmthiaceutical Technology & Innovation, 04 (21); 2016; Research Article

Pelagia Research Library

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR DETERMINATION APIXABAN IN BULK AND TABLETS

IJRPC 2011, 1(4) Rohan et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form

INTRODUCTION. safety and efficacy throughout all phases of its shelf life, including storage. In

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Quantitative estimation of Rosuvastatin in bulk and tablet dosage form by using area under curve method

World Journal of Pharmaceutical Research

Development and validation of HPTLC method for determination of Telmisartan in API and pharmaceutical dosage form

MEHUL M. PATEL a*, HETA D. PATEL a

UV Spectrophotometric Estimation of Alprazolam by Area Under Curve And First Order Derivative Methods in Bulk and Pharmaceutical Dosage Form

Determination of tramadol in capsules by high performance thin layer chromatography - densitometry

A NOVEL RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF BERBERINE, QUERCETIN, AND PIPERINE IN AN AYURVEDIC FORMULATION

Pelagia Research Library. Validated HPTLC Method for Simultaneous Estimation of Ramipril and Metolazone in Bulk Drug and Formulation

Available online at Scholars Research Library

Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2

The present manuscript describes simple, sensitive, rapid, accurate, precise and cost effective First derivative

Pankti M. Shah et al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; 07-16

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

Development and Validation of a New Uv Method for the Analysis of Rebamipide

Journal of Chemical and Pharmaceutical Research

Scholars Research Library

Research Article Simultaneous Estimation of Four Antitussive Components from Herbal Cough Syrup by HPTLC

Impact factor: 3.958/ICV:

Standardization of Milagathi Choornam

SULTANA SHAIKH, VANDANA JAIN *

Development and Validation of HPTLC Method for Quantification of Biomarker β-sitosterol in Derris heyneana (Wight and Arn) Benth

Available online Research Article

Pelagia Research Library

Development and Validation of Analytical Method for Determination of Andrographolide in Bulk Powder

Corresponding Author:

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

Validation of UV Spectrophotometric and HPLC Methods for Quantitative determination of Iloperidone in Pharmaceutical Dosage Form

ISSN (Print)

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

for Methotrexate. The result of analysis has been validated statistically and recovery studies confirmed the accuracy of

Method Development and Validation for the Estimation of Saroglitazar in Bulk and Pharmaceutical Dosage Form by RP-HPLC

Development and validation for the simultaneous quantification of Montelukast and Levocetirizine by UV, RP-HPLC and HPTLC methods in tablets

Stability indicating RP-HPLC method development and validation of Etizolam and Propranolol hydrochloride in pharmaceutical dosage form

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

Int. J. Pharm. Sci. Rev. Res., 21(2), Jul Aug 2013; nᵒ 19,

Pelagia Research Library

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

QUANTITATIVE ESTIMATION OF PIPERINE COUGH SYRUP BY HPTLC METHOD

Journal of Chemical and Pharmaceutical Research

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR CILOSTAZOL IN TABLET DOSAGE FORM

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

International Journal of Pharma and Bio Sciences V1(1)2010

Stability-indicating Simultaneous HPTLC Method for Olanzapine and Fluoxetine in Combined Tablet Dosage Form

Comparative study of analytical method development of fluconazole in tablets and capsule by ultraviolet spectrophotometric method

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

Research Article. ISSN Available online at 746

Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form

Received: 29 Oct 2013, Revised and Accepted: 20 Oct 2013

Journal of Chemical and Pharmaceutical Research

Development and validation of a RP-HPLC method for the simultaneous determination of Embelin, Rottlerin and Ellagic acid in Vidangadi churna

AMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

Development and validation of related substances method for Varenicline and its impurities

Transcription:

International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol. 3, No.2, pp 986-999, April-June 2011 HPTLC Method for estimation of Gallic acid and Rutin in Haritaki -An Ayurvedic Formulation Rajasekaran.A, Arivukkarasu.R. and Archana.D.* Department of Pharmaceutical Analysis, KMCH College Of Pharmacy, Kovai Estate, Kalapatti Road, Coimbatore-641035, India. *Corres. author:archanapharma09@yahoomail.com Phone No. 09789777376 Abstract: Standardization of Herbal Formulation is essential to assess the quality of drugs based on the concentration of their active principle. Haritaki possess a wide variety of activities like antimicrobial, antioxidant, antispasmodic and antipurgative. In the present study, an attempt has been made to develop simple, precise and accurate HPTLC method for Haritaki on Laboratory Formulation (LF) and it is compared with different Marketed Formulation (MF 1, MF 2, MF 3, MF 4 ) by estimating Gallic acid and Rutin as a marker compound. The Five different Formulations were subjected to methanolic extract by Maceration process for 7 days. The detection and quantification of Gallic acid and Rutin were performed at 280 nm and 254 nm respectively. The linearity of Gallic acid and Rutin were found to be 100-500 ng/spot and 1000-5000 ng/spot. The correlation coefficient of Gallic acid and Rutin was found to be 0.9967 and 0.9974 respectively. The Percentage recovery of Gallic acid and Rutin were found to be 99.12%w/w and 97.85%w/w respectively which is highly satisfactory. The LOD and LOQ of Gallic acid were found to be 70.96 ng/spot and 212.89 ng/spot respectively. The LOD and LOQ of Rutin were found to be 63.19 ng/spot and 189.57 ng/spot respectively. The overlay spectrums of standard Gallic acid with sample (LF and MF) were found to be similar and the method was found to be very specific. Since this proposed validated method resolves and quantifies Gallic acid and Rutin effectively, it can be used routinely to quantify the concentration of both the active principles in the herbal formulation Keywords: HPTLC, Haritaki, Rutin, Gallic acid, Laboratory Formulation and Marketed Formulation. 1. Introduction: Terminalia Chebula has been extensively used in ayurveda, unani & homoeopathic medicine and has become cynosure of modern medicine. The Sanskrit name Haritaki is rich with meaning, reffering to the yellowish dye (harita) that contains the god Siva (Hari, i.e. the Himalayas) and that it cures (harayet) all the disease. Its other commonly used Sanskrit name, Abhaya, refers to the fearlessness it provides in the face of the disease. According to Indian mythology, this plant originated from the drops of ambrosia (Amrita) which fell on the earth when Indra was drinking it 1, 2. T. Chebula possesses a wide variety of activities like antimicrobial, antioxidant, antiviral, anticarcinogenic, hypocholesterolemic, radio - protective, antispasmodic & antipurgative 3. Gallic acid is phenyl propanoid, chemically it is 3, 4, 5,- Trihydroxybenzoic acid, and possess astringent activity. Flavonoids are a group of polyphenolic compounds, which are widely distributed throughout the plant kingdom. To date about 300 varieties of flavonoids are known 4. Many have low toxicity in mammals and some of them are widely used in medicine for maintenance of capillary integrity. Rutin, 5, 7, 3, 4, tetrahydroxy flavonol -3-rhamnoglucoside and quercetin 5, 7, 3, 4, - tetrahydroxy flavonol exhibit anti-inflammatory, anti hepatotoxic, antiulcer, antiallergic and antiviral actions and some of them provides protection against cardiovascular mortality. Both possess antioxidant activity and reduce low density lipoproteins (LDL) oxidation 5. Phytochemical evaluation is one of the tools for the quality

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 987 assessment, which includes preliminary phytochemical screening, chemoprofiling and marker compound analysis using modern analytical techniques. In the last two decades high performance thin layer chromatography (HPTLC) method has emerged as an important tool for the qualitative and quantitative phytochemical analysis of herbal drugs and formulations 6. A suitable, sensitive, and reliable quantitative high-performance thin-layer chromatographic (HPTLC) method has been developed for the first time for quality control determinations of gallic acid and Rutin in Terminallia chebula. Presently, this technique is being used extensively for quantification of these compounds in plant extracts and marketed formulation because of its simplicity, accuracy, cost effectiveness, and rapidity. 2. Experimental Methods 2.1. Instrumentation Analysis was performed on a Camag HPTLC system equipped with a sample applicator Linomat V, twin trough development chamber (10x10) size, TLC Scanner III, Wincats integration software was used. 2. 2. Reagents and Chemicals Analytical grade Toluene, Ethyl acetate, Methanol, Formic acid, Chloroform, glacial acetic acid was obtained from SD fine chem. Ltd, Mumbai. Pure Gallic acid and Rutin were obtained from the Natural Remedies Ltd, Bangalore. Precoated TLC aluminium sheets silica gel 60F 254 (10 x10 cm, 0.2 mm thick) were obtained from E. Merck Ltd, Mumbai. 2.3. Collection of Raw Material Terminalia chebula (Haritaki) were collected from the local market and physically authenticated with herbarium specimens present in Pharmacognosy laboratory for its genuine. The Marketed Formulations Haritaki (MF 1, MF 2, MF 3, MF 4) were obtained from local Ayurvedic pharmacy, Coimbatore, Tamilnadu. 2.4. Preparation of Standard Gallic acid and Rutin Solution 10 mg of Gallic acid and Rutin were accurately weighed into 10 ml volumetric flask, and then the solution was made up to 10ml with methanol (1mg ml -1 ) 7. From the Stock solution of gallic acid 1ml was pipette out and further diluted upto 10 ml to obtain the final concentration of 100 µg/ml. 2.5. Preparation of Extracts The dried fruit pulp of Terminalia chebula the Laboratory Formulation (5 gm) and different Marketed formulation sample (5 gm) of Haritaki were extracted by Maceration process in 100ml of methanol for 7 days. The methanolic extract was filtered through Whatmann Filter paper No.1 and then concentrated at low temperature. The stock solutions were further diluted to produce a uniform concentration of 10 mg ml -1 for both the samples. 2.6. Chromatographic Conditions Samples of methanolic extracts of LF and CF of Haritaki and standard Gallic acid and Rutin were spotted on a Precoated TLC aluminium sheets silica gel 60 F 254 (10x10cm, 0.2mm thickness) as 8mm wide band width by using automatic TLC applicator Linomat V,10mm from the bottom. The Mobile phase used was Toluene: Ethyl acetate: Formic acid (3:6:1v/v) for Gallic acid and Chloroform: Ethyl acetate: Methanol: Formic acid (3.5:5:0.5:1 v/v) for Rutin.The plates were kept for saturation in twin trough chamber for 15min. After development the plates were dried in air and scanned at 280 nm for Gallic acid and 254 nm for Rutin by using CAMAG Scanner III. The plates were photographed at 254 nm by using CAMAG Reprostar instrument and shown in (Fig.1, 2). 2.8. Calibration Curve for Standard Gallic acid The standard solutions (100-500 ng/spot) were applied on TLC plate and further it was developed and scanned as per the chromatographic conditions mentioned above. The peak areas were recorded. Calibration curve of gallic acid was prepared by plotting peak area against concentration of gallic acid applied. 2.9. Calibration Curve for Standard Rutin The standard solutions (1000-5000 ng/spot) were applied on TLC plate and further it was developed and scanned as per the chromatographic conditions mentioned above. The peak areas were recorded. Calibration curve of rutin was prepared by plotting peak area against concentration of rutin applied.

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 988 Table 1. Quantification of Gallic acid and Rutin in Haritaki Formulations. Sample Amount Present Gallic acid (%w/w) Rutin (%w/w) LF 0.9936 0.9452 MF1 0.9732 0.9154 MF2 0.9689 0.8907 MF3 0.9849 0.9281 MF4 0.9901 0.9361 Table 2. Recovery studies for Gallic acid and Rutin in Haritaki. Compound Contents (mg) Amount added (mg) Recorded amount (mg) Recovery (%) Gallic acid 2 6.149 97.99 4.128 4 8.269 99.29 6 10.421 99.76 Rutin 2 4.721 97.81 2.889 4 6.291 96.42 6 8.194 99.32 Table 3.Summary of Validation parameter PARAMETERS GALLIC ACID RUTIN Linearity i) Range 100-500 ng/spot 1-5 mg/spot ii)correlation 0.9967 0.9973 Coefficient iii) Rf Value 0.41 0.13 Precision (%RSD) i) Intra-day 0.9013 0.4729 ii) Inter-day 0.604 0.7254 iii) Repeatability 0.9769 0.5959 LOD 70.96 ng/spot 63.19 ng/spot LOQ 212.89 ng/spot 189.57 ng/spot Ruggedness (%RSD) 0.9416 0.8114 Specificity Specific Specific Robustness Robust Robust Plate Efficiency 24.88 mm 24.88 mm Flow constant 4.9 mm 2 /s 6.125 mm 2 /s Fig.1. Photo documentation of Gallic acid at 254 nm

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 989 Fig.2. Photo documentation of Rutin at 254 nm Fig.3. Calibration curve for gallic acid

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 990 Fig.4. Calibration curve for Rutin Fig.5. Chromatogram of standard gallic acid

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 991 Fig.6. Chromatogram of standard Rutin Fig.7. Chromatogram of Laboratory Formulation Haritaki (Gallic acid)

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 992 Fig.8. Chromatogram of Marketed Formulation Haritaki 1 (Gallic acid) Fig.9. Chromatogram of Marketed Formulation Haritaki 2 (Gallic acid)

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 993 Fig.10. Chromatogram of Marketed Formulation Haritaki 3 (Gallic acid) Fig.11. Chromatogram of Marketed Formulation Haritaki 4 (Gallic acid

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 994 Fig.12. Chromatogram of Laboratory formulation Haritaki (Rutin) Fig.13. Chromatogram of Marketed Formulation Haritaki 1(Rutin)

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 995 Fig.14. Chromatogram of Marketed Formulation Haritaki 2 (Rutin) Fig.15. Chromatogram of Marketed Formulation Haritaki 3 (Rutin)

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 996 Fig.16. Chromatogram of Marketed Formulation Haritaki 4 (Rutin) Fig.17. Overlay Spectrum of Gallic acid

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 997 Fig.18. Overlay Spectrum of Rutin 3. Results and Discussion 3.1. Optimization of HPTLC Chromatographic Conditions: Standard Gallic acid (RF: 0.41) and Rutin (RF: 0.13) showed single peaks in HPTLC chromatogram. The amount of Gallic acid and Rutin present in the above formulation were computed from the above calibration curve. The linearity of Gallic acid and Rutin were found to be 100-500 ng/spot and 1-5 µg/spot. The correlation coefficient of Gallic acid and Rutin was found to be 0.9967 and 0.9974 respectively. The Percentage recovery of Gallic acid and Rutin were found to be 99.42%w/w and 97.14%w/w respectively which is highly satisfactory. The LOD and LOQ of Gallic acid were found to be 70.96 ng/spot and 212.89 ng/spot respectively. The LOD and LOQ of Rutin were found to be 63.19 ng/spot and 189.57 ng/spot respectively. The method was found to be very specific. Since the overlay spectrums of standard Gallic acid with sample (LF and MF) were found to be similar. 3.2. Quantification of Markers present in Haritaki Formulations: The contents of the active compounds were quantified using calibration curve (Fig.3, 4) of each marker individually (Fig.5, 6). The two markers used for quantification were found and well separated by proposed method in Haritaki formulations (Fig.7-16). The Result obtained was shown in (Table1). 3.3. Validation of the Proposed Method ICH guidelines were followed for the validation of the analytical methods developed (precision, repeatability, accuracy, Ruggedness, Robustness, Plate efficiency, Flow constant 8. Summary of validation parameters was listed out in (Table 3). 3.3.1. Linearity: A representative calibration curve of gallic acid and rutin were obtained by plotting the peak area of gallic acid and rutin against the concentration of gallic acid (100-500 ng/spot) and Rutin (1-5 µg/spot), respectively. The correlation coefficient of gallic acid and rutin were found to be 0.9967 and 0.9973, respectively and thus exhibits the good linearity between concentration and peak area. 3.3.2. Inter-day and intra-day precision: The inter-day precision (RSD) was determined by analyzing standard solution of Gallic acid and Rutin over the entire calibration range for three different days. The intra-day precision (RSD) was determined by analyzing standard solution of Gallic acid and Rutin over the entire calibration range for three times on the same day 3.3.3. Repeatability: Repeatability of measurement of peak area and peak height: Standard Gallic acid and Rutin solution was spotted on a TLC plate, developed and dried. The separated spot was scanned for six times without

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 998 changing plate position and RSD for measurement of peak area was computed. 3.3.4. Limit of Detection: The minimum detectable limit was found to be 70.96 ng/spot for gallic acid and 63.19 ng/spot for rutin. 3.3.5. Limit of Quantification: The minimum quantified limit was found to be 212.89 ng/spot for gallic acid and 189.57 ng/spot for rutin. 3.3.6. Specificity: It was observe that other constituents presents in the formulation did not interfere either with the peak of gallic acid and rutin. Therefore the method was specific. The overlay spectrum of standard gallic acid and rutin spots and gallic acid and rutin spots present in the samples were found to be similar or overlap. The peak purity of the gallic acid was assessed by comparing the spectra at three different levels, viz. peak start, peak apex and peak end positions of the spot. The overlay spectrum was shown in (Fig 17, 18). 3.3.7. Robustness of the method: By introducing small changes in the mobile phase composition, mobile phase volume and duration of mobile phase saturation, the effects on the results were examined. Robustness of the method was done in triplicate at a concentration level of 2µg/spot and the %R.S.D. of peak area was calculated. 3.3.8. Ruggedness of the method: It expresses the precision within laboratories variations like different days, different analyst, and different equipment. Ruggedness of the method was assessed by spiking the standard 6 times in two different days with different analyst. 3.3.9. Plate efficiency (N): Plate efficiency, also known as number of theoretical plates was calculated for the described method by the following equation: 16 x l x z N = ------------- w 2 Where, l is the distance (in mm) traveled by solvent front, z is the distance (in mm) traveled by the target spot from application point and w is the width of spot (in mm) in the direction of mobile phase ascending. The plate efficiency was calculated for gallic acid and rutin and it was found to be 24.88 mm respectively. 3.3.10. Flow constant: The Flow constant or velocity constant (k) is a measure of the migration rate of the solvent front. It is an important parameter for TLC users and can be used to calculate, for example, development times with different separation distances, provided that the sorbent, solvent system, chamber type and temperature remain constant. The flow constant is given by the following equation: Z F 2 k = ---------- t Where, k is flow constant [mm 2 /s], Z F is distance between the solvent front and the solvent level [mm] and t is the development time [s]. The flow constant as calculated by this method was found to be 4.9 mm 2 s -1 and 6.12 mm 2 s -1. 3.3.11. Accuracy: The accuracy was determined by standard addition method. To a fixed amount of preanalyzed sample of Haritaki, increasing amount of standard Gallic acid and Rutin were added in all the levels of calibration curve. The Percentage recovery of Gallic acid and Rutin were calculated at each level (n = 3) and shown in (Table 2). 4. Conclusion: Standardization of Haritaki as well as raw materials is important as per analysis of formulation is concerned. The results indicate that Haritaki contains a number of markers that may be responsible for its therapeutic activity. The developed HPTLC method will assist in the standardization of Haritaki using biologically active chemical markers. The marker content of laboratory Haritaki was found higher than that of market samples of Haritaki by HPTLC method, may be due to use of inferior quality of materials in the preparation of tablets. The proposed Validated HPTLC method for Gallic acid and rutin from Haritaki seems to be accurate, precise, reproducible and repeatable. Haritaki also contained a number of other constitute, which are currently the subject of further investigation, apart from those standards studied. Also profiles of the individual components in Haritaki have been recorded as a standardization tool. With the growing demand for herbal drugs and with increased belief in the usage of herbal medicine, this standardization tool will help in maintaining the quality and batch to batch consistency of this important Ayurvedic preparation. 5. Acknowledgement The authors are grateful to Dr.A.Rajasekaran, Principal and Staff member in KMCH college of Pharmacy Coimbatore, for providing facilities to carry out the research work.

Archana.D.et al /Int.J. PharmTech Res.2011,3(2) 999 6. References 1) B Das, Materia Medica of Ayurveda. (B Jain Publisher, New Delhi) 1991, 8. 2) Debjit Bhowmik, K.P.Sampath Kumar, Pankaj Tripathi, Chiranjib.B, Traditional Herbal Medicines: An Overview Scholars Research Library 2009, 1 (2), 165-177. 3) Anonymous,The Ayurvedic Formulary of India. Part-II, Govt. of India, Ministry of Health and Family Welfare, Dept. of Indian Systems of Medicine and Homeopathy, New Delhi. 110. 4) Anonymous,The Indian Pharmacopoeia 1996, Part-II, Appendix-3, Govt. of India, Ministry of Health and Family Welfare. A-34. 5) Anonymous, Quality Standards of Indian Medicinal Plants, Vol-I, Published by Indian Council of Medicinal Research, 2003. 6) N.S. Jeganadhan, K.Kannan, HPTLC Method for estimation of ellagic acid and gallic acid in Triphala churnam Formulation, Res.Journal of Phytochem, 2008, 2(1), 1-9. 7) Ashok Kumar, K.Lakshman et al, Estimation of Gallic acid, Rutin and Quercetin in Terminalia chebula by HPTLC, Jordan Journal of Ph.Sciences, 2010, 3(1), 63-66. 8) International Conference on Harmonization, Guideline on Validation of Analytical Procedure-Methodology, Geneva, Switzerland 1996. 9) ICH Harmonized Tripartite Guidelines, Validation of Analytical Procedures Text and Methodolgy, 1994, Q2R (1). *****